Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination

백신에 불응하는 자가면역 류마티스 질환이 있는 B 세포 고갈 환자에서 SARS-CoV-2에 대한 전신 및 점막 면역에 대한 카시리비맙/임데비맙의 효과

Published on 2022-05-012022-09-12
Journal: RMD Open

[저자] Filippo Fagni, Katja Schmidt, Daniela Bohr, Larissa Valor-Méndez, Fabian Hartmann, Koray Tascilar, Karin Manger, Bernhard Manger, Arnd Kleyer, David Simon, Georg Schett, Thomas Harrer

[Category] COVID19(2023년), MERS, SARS, 진단,

PMC URL [DOI] 10.1136/rmdopen-2022-002323

[Article Type] Article

[Source] PMC

No abstract available
Keywords: Autoimmune Diseases; COVID-19; Epidemiology; Rituximab; Vaccination.

All Keywords
【저자키워드】 COVID-19, vaccination, Epidemiology, rituximab, Autoimmune diseases, 【초록키워드】 Abstract, 【제목키워드】 SARS-CoV-2, vaccination, Immunity, Patient, Autoimmune, B-cell, mucosal, rheumatic disease, Effect,

사용 가능한 초록 없음 {{ 키워드: }} 자가면역 질환; 코로나바이러스감염증-19 : 코로나19; 역학; 리툭시맙; 백신 접종.